Literature DB >> 18624959

The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among Men.

Naomi M Gades1, Debra J Jacobson, Michaela E McGree, Jennifer L St Sauver, Michael M Lieber, Ajay Nehra, Cynthia J Girman, George G Klee, Steven J Jacobsen.   

Abstract

INTRODUCTION: Testosterone replacement therapy has been used in the treatment of sexual dysfunction; however, its use remains controversial, and the effectiveness and long-term health implications are unknown. AIM: To evaluate the association between sex hormone serum levels, erectile function, and sexual drive in a population-based sample of men.
METHODS: A stratified random sample of men residing in Olmsted County, Minnesota, completed a questionnaire containing questions from the Brief Male Sexual Function Inventory (BMSFI), and participated in a clinical exam, which included serum hormone measurements. MAIN OUTCOME MEASURES: Levels of sexual drive (libido) and erectile function as assessed by the BMSFI and serum testosterone, bioavailable testosterone, and estradiol measurements.
RESULTS: Out of 414 men, 294 had a regular sexual partner and androgen measurements at the 14th year of follow-up. Total testosterone and erectile function were significantly correlated even after adjustment for age (r = 0.12, P = 0.04). Conversely, total testosterone was not significantly correlated with sex drive (r = 0.08, P = 0.17). Bioavailable testosterone was significantly correlated with both erectile function and sex drive (r = 0.16, P = 0.01 and r = 0.20, P = 0.001, respectively). However, these associations disappeared after age adjustment (r = 0.04 and r = 0.09).
CONCLUSIONS: These cross-sectional results suggest the relationship between sex hormones and sexual function is complex, and that the age-related decline in sexual function may be due to age-related declines in levels of bioavailable testosterone rather than total testosterone levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624959      PMCID: PMC2586969          DOI: 10.1111/j.1743-6109.2008.00924.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  37 in total

Review 1.  Quality of life and erectile dysfunction.

Authors:  Stanley E Althof
Journal:  Urology       Date:  2002-06       Impact factor: 2.649

2.  The prevalence of prostatism: a population-based survey of urinary symptoms.

Authors:  C G Chute; L A Panser; C J Girman; J E Oesterling; H A Guess; S J Jacobsen; M M Lieber
Journal:  J Urol       Date:  1993-07       Impact factor: 7.450

3.  Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction.

Authors:  John P Mulhall; Rolando Valenzuela; Nadid Aviv; Marilyn Parker
Journal:  Urology       Date:  2004-02       Impact factor: 2.649

Review 4.  Erectile dysfunction: management update.

Authors:  Luke Fazio; Gerald Brock
Journal:  CMAJ       Date:  2004-04-27       Impact factor: 8.262

Review 5.  11: Androgen deficiency and replacement therapy in men.

Authors:  David J Handelsman; Jeffrey D Zajac
Journal:  Med J Aust       Date:  2004-05-17       Impact factor: 7.738

6.  Bioavailable testosterone with age and erectile dysfunction.

Authors:  Akira Tsujimura; Kiyomi Matsumiya; Yasuhiro Matsuoka; Tohru Takahashi; Minoru Koga; Atsushi Iwasa; Masami Takeyama; Akihiko Okuyama
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

7.  Testicular testosterone and dihydrotestosterone during sexual development in humans.

Authors:  M A Rivarola; T Pasqualini; H E Chemes
Journal:  J Steroid Biochem       Date:  1983-07       Impact factor: 4.292

8.  Temporal trends in the incidence of coronary disease.

Authors:  Theresa J Arciero; Steven J Jacobsen; Guy S Reeder; Robert L Frye; Susan A Weston; Jill M Killian; V éronique L Roger Vr
Journal:  Am J Med       Date:  2004-08-15       Impact factor: 4.965

9.  Serum sex hormones and measures of benign prostatic hyperplasia.

Authors:  Rosebud O Roberts; Debra J Jacobson; Thomas Rhodes; George G Klee; Michael M Leiber; Steven J Jacobsen
Journal:  Prostate       Date:  2004-10-01       Impact factor: 4.104

10.  Distribution of the Brief Male Sexual Inventory in community men.

Authors:  M P O'Leary; T Rhodes; C J Girman; D J Jacobson; R O Roberts; M M Lieber; S J Jacobsen
Journal:  Int J Impot Res       Date:  2003-06       Impact factor: 2.896

View more
  10 in total

1.  Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.

Authors:  Glenn R Cunningham; Alisa J Stephens-Shields; Raymond C Rosen; Christina Wang; Shalender Bhasin; Alvin M Matsumoto; J Kellogg Parsons; Thomas M Gill; Mark E Molitch; John T Farrar; David Cella; Elizabeth Barrett-Connor; Jane A Cauley; Denise Cifelli; Jill P Crandall; Kristine E Ensrud; Laura Gallagher; Bret Zeldow; Cora E Lewis; Marco Pahor; Ronald S Swerdloff; Xiaoling Hou; Stephen Anton; Shehzad Basaria; Susan J Diem; Vafa Tabatabaie; Susan S Ellenberg; Peter J Snyder
Journal:  J Clin Endocrinol Metab       Date:  2016-06-29       Impact factor: 5.958

Review 2.  Androgens are fundamental in the maintenance of male sexual health.

Authors:  Alvaro Morales
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 3.  Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction.

Authors:  Carol A Podlasek; John Mulhall; Kelvin Davies; Christopher J Wingard; Johanna L Hannan; Trinity J Bivalacqua; Biljana Musicki; Mohit Khera; Nestor F González-Cadavid; Arthur L Burnett
Journal:  J Sex Med       Date:  2016-08       Impact factor: 3.802

4.  Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes.

Authors:  Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; George G Klee; Michael M Lieber; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2011-03-02       Impact factor: 4.897

5.  Sex Steroid Hormone Levels May Not Explain Gender Differences in Development of Nephrolithiasis.

Authors:  John Joseph Knoedler; Amy E Krambeck; Walter Astorne; Erik Bergstralh; John Lieske
Journal:  J Endourol       Date:  2015-11-05       Impact factor: 2.942

6.  Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials.

Authors:  Glenn R Cunningham; Alisa J Stephens-Shields; Raymond C Rosen; Christina Wang; Susan S Ellenberg; Alvin M Matsumoto; Shalender Bhasin; Mark E Molitch; John T Farrar; David Cella; Elizabeth Barrett-Connor; Jane A Cauley; Denise Cifelli; Jill P Crandall; Kristine E Ensrud; Laura Fluharty; Thomas M Gill; Cora E Lewis; Marco Pahor; Susan M Resnick; Thomas W Storer; Ronald S Swerdloff; Stephen Anton; Shehzad Basaria; Susan Diem; Vafa Tabatabaie; Xiaoling Hou; Peter J Snyder
Journal:  J Clin Endocrinol Metab       Date:  2014-12-30       Impact factor: 5.958

7.  Longitudinal evaluation of sexual function in a male cohort: the Olmsted county study of urinary symptoms and health status among men.

Authors:  Naomi M Gades; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; Michael M Lieber; Ajay Nehra; Cynthia J Girman; Steven J Jacobsen
Journal:  J Sex Med       Date:  2009-06-29       Impact factor: 3.802

8.  Testosterone is associated with erectile dysfunction: a cross-sectional study in Chinese men.

Authors:  Ming Liao; Xianghua Huang; Yong Gao; Aihua Tan; Zheng Lu; Chunlei Wu; Youjie Zhang; Xiaobo Yang; Haiying Zhang; Xue Qin; Zengnan Mo
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

Review 9.  The Relationship between Testosterone Deficiency and Men's Health.

Authors:  Akira Tsujimura
Journal:  World J Mens Health       Date:  2013-08-31       Impact factor: 5.400

Review 10.  Modifying Risk Factors in the Management of Erectile Dysfunction: A Review.

Authors:  Kenneth J DeLay; Nora Haney; Wayne Jg Hellstrom
Journal:  World J Mens Health       Date:  2016-08-23       Impact factor: 5.400

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.